These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Prognostic significance of NADPH quinine oxidoreductase 1 overexpression in head and neck squamous cell carcinoma]. Yang Y; Jin T; Liu S; Chen L; Lin L; Han H; Li L; Lin Z Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):463-7. PubMed ID: 25327796 [TBL] [Abstract][Full Text] [Related]
5. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas. Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421 [TBL] [Abstract][Full Text] [Related]
6. The PRiMA-linked cholinesterase tetramers are assembled from homodimers: hybrid molecules composed of acetylcholinesterase and butyrylcholinesterase dimers are up-regulated during development of chicken brain. Chen VP; Xie HQ; Chan WKB; Leung KW; Chan GKL; Choi RCY; Bon S; Massoulié J; Tsim KWK J Biol Chem; 2010 Aug; 285(35):27265-27278. PubMed ID: 20566626 [TBL] [Abstract][Full Text] [Related]
7. High tRNA Transferase NSUN2 Gene Expression is Associated with Poor Prognosis in Head and Neck Squamous Carcinoma. Lu L; Zhu G; Zeng H; Xu Q; Holzmann K Cancer Invest; 2018 Apr; 36(4):246-253. PubMed ID: 29775108 [TBL] [Abstract][Full Text] [Related]
8. The prognostic value of glycerol-3-phosphate dehydrogenase 1-like expression in head and neck squamous cell carcinoma. Feng Z; Li JN; Wang L; Pu YF; Wang Y; Guo CB Histopathology; 2014 Feb; 64(3):348-55. PubMed ID: 24274692 [TBL] [Abstract][Full Text] [Related]
9. Butyrylcholinesterase and the control of synaptic responses in acetylcholinesterase knockout mice. Girard E; Bernard V; Minic J; Chatonnet A; Krejci E; Molgó J Life Sci; 2007 May; 80(24-25):2380-5. PubMed ID: 17467011 [TBL] [Abstract][Full Text] [Related]
10. Analysis of cholinesterases in human prostate and sperm: implications in cancer and fertility. Nieto-Cerón S; Vargas-López H; Pérez-Albacete M; Tovar-Zapata I; Martínez-Hernández P; Rodríguez-López JN; Cabezas-Herrera J Chem Biol Interact; 2010 Sep; 187(1-3):432-5. PubMed ID: 20356562 [TBL] [Abstract][Full Text] [Related]
11. Telomerase as an independent prognostic factor in head and neck squamous cell carcinoma. Liao CT; Tung-Chieh Chang J; Wang HM; Chen IH; Lin CY; Chen TM; Hsieh LL; Cheng AJ Head Neck; 2004 Jun; 26(6):504-12. PubMed ID: 15162351 [TBL] [Abstract][Full Text] [Related]
12. On-site analysis of acetylcholinesterase and butyrylcholinesterase activity with the ChE check mobile test kit-Determination of reference values and their relevance for diagnosis of exposure to organophosphorus compounds. Worek F; Schilha M; Neumaier K; Aurbek N; Wille T; Thiermann H; Kehe K Toxicol Lett; 2016 May; 249():22-8. PubMed ID: 27033775 [TBL] [Abstract][Full Text] [Related]
13. Loss of the putative tumor suppressor protein spinophilin is associated with poor prognosis in head and neck cancer. Aigelsreiter AM; Aigelsreiter A; Wehrschuetz M; Ress AL; Koller K; Salzwimmer M; Gerger A; Schauer S; Bauernhofer T; Pichler M Hum Pathol; 2014 Apr; 45(4):683-90. PubMed ID: 24565202 [TBL] [Abstract][Full Text] [Related]
14. MERTK as a novel therapeutic target in head and neck cancer. von Mässenhausen A; Sanders C; Thewes B; Deng M; Queisser A; Vogel W; Kristiansen G; Duensing S; Schröck A; Bootz F; Brossart P; Kirfel J; Heasley L; Brägelmann J; Perner S Oncotarget; 2016 May; 7(22):32678-94. PubMed ID: 27081701 [TBL] [Abstract][Full Text] [Related]
15. LTBP2 is a prognostic marker in head and neck squamous cell carcinoma. Han L; Tang MM; Xu X; Jiang B; Huang J; Feng X; Qiang J Oncotarget; 2016 Jul; 7(29):45052-45059. PubMed ID: 27281608 [TBL] [Abstract][Full Text] [Related]
16. L-DOPA decarboxylase mRNA expression is associated with tumor stage and size in head and neck squamous cell carcinoma: a retrospective cohort study. Geomela PA; Kontos CK; Yiotakis I; Fragoulis EG; Scorilas A BMC Cancer; 2012 Oct; 12():484. PubMed ID: 23083099 [TBL] [Abstract][Full Text] [Related]
17. Second primary lung cancers following a diagnosis of primary head and neck cancer. Griffioen GH; Louie AV; de Bree R; Smit EF; Paul MA; Slotman BJ; Leemans CR; Senan S Lung Cancer; 2015 Apr; 88(1):94-9. PubMed ID: 25662386 [TBL] [Abstract][Full Text] [Related]
18. Cancer-associated differences in acetylcholinesterase activity in bronchial aspirates from patients with lung cancer. Martínez-López de Castro A; Nieto-Cerón S; Aurelio PC; Galbis-Martínez L; Latour-Pérez J; Torres-Lanzas J; Tovar-Zapata I; Martínez-Hernández P; Rodríguez-López JN; Cabezas-Herrera J Clin Sci (Lond); 2008 Oct; 115(8):245-53. PubMed ID: 18211261 [TBL] [Abstract][Full Text] [Related]
19. Expression of cholinesterases in human kidney and its variation in renal cell carcinoma types. Muñoz-Delgado E; Montenegro MF; Campoy FJ; Moral-Naranjo MT; Cabezas-Herrera J; Kovacs G; Vidal CJ FEBS J; 2010 Nov; 277(21):4519-29. PubMed ID: 20883446 [TBL] [Abstract][Full Text] [Related]
20. Proteoglycan-based diversification of disease outcome in head and neck cancer patients identifies NG2/CSPG4 and syndecan-2 as unique relapse and overall survival predicting factors. Farnedi A; Rossi S; Bertani N; Gulli M; Silini EM; Mucignat MT; Poli T; Sesenna E; Lanfranco D; Montebugnoli L; Leonardi E; Marchetti C; Cocchi R; Ambrosini-Spaltro A; Foschini MP; Perris R BMC Cancer; 2015 May; 15():352. PubMed ID: 25935541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]